Eton Pharmaceuticals Inc

NASDAQ:ETON  
3.25
+0.06 (+1.88%)
Earnings Announcements

Eton Pharmaceuticals Reports First Quarter 2022 Financial Results

Published: 05/12/2022 21:10 GMT
Eton Pharmaceuticals Inc (ETON) - Eton Pharmaceuticals Reports First Quarter 2022 Financial Results.
Q1 Loss per Share $0.21.
Revenue is expected to be $9.5 Million
Adjusted EPS is expected to be $0.06

Next Quarter Revenue Guidance is expected to be $5.1 Million
Next Quarter EPS Guidance is expected to be $0.03

More details on our Analysts Page.